Israel Biotech Fund
Andrew J. Einhorn is a Venture Advisor at Israel Biotech Fund. Andrew is also the CFO at Osmotica Pharmaceutical and the former CFO at Edge Therapeutics; Mr. Einhorn is a Financial Executive & Entrepreneur with more than 12 years of experience in the pharmaceutical industry has been a co-founder and Chief Financial officer of several pharmaceutical and biotech companies. He also has more than 20 years of experience as an investment banker working extensively in corporate finance, capital markets, and financial analysis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.